Merit Medical Systems | MMSI - Operating Profit


Merit Medical Systems reported $54.2M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
3M USD 1.21B 394M Dec/2025
Abbott USD 2.25B 73M Dec/2025
AngioDynamics USD -9.97M 1.12M Feb/2025
Anika Therapeutics USD -4.28M 32.1M Mar/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Olympus JPY 28B 5.56B Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 43.88B 1.21B Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025